Published in
BMJ Publishing Group, BMJ, 7635(336), p. 80-84, 2008
DOI: 10.1136/bmj.39421.435949.be
Links
- ORCID
- ORCID
- BMJ Publishing Group
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study)
Journal article published in 2008 by
Rai Asghar,
Salem Banajeh,
Josefina Egas,
Patricia Hibberd,
Imran Iqbal,
Mary Katep-Bwalya,
Zafarullah Kundi,
Paul Law,
William MacLeod 
,
Irene Maulen-Radovan,
Greta Mino,
Samir Saha,
Fernando Sempertegui,
Jonathon Simon,
Mathuram Santosham
and other authors.
,
Irene Maulen-Radovan,
Greta Mino,
Samir Saha,
Fernando Sempertegui,
Jonathon Simon,
Mathuram Santosham
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Objective To evaluate whether five days’ treatment with injectable ampicillin plus gentamicin compared with chloramphenicol reduces treatment failure in children aged 2-59 months with community acquired very severe pneumonia in low resource settings.